It is not uncommon for small biotech and biopharma startup companies to overlook Quality & Compliance when formulating their drug development plans and budgets. However,...
While the world focuses on COVID-19, NGT’s Michael K. O’Brien and Philip Chu provide insight on the current state of the market for antimicrobial resistant (AMR) medicines....
Alton Johnson is an industry leader and expert in pharmaceutical development, manufacturing, technology and business solutions. In his current consulting role, he develops...
2020 ISPE Facilities of the Future Conference
Training 28 - 29 Jan | Conference 30 - 31 Jan 2020, San Francisco
Presenter: Michael O’Brien - Presentation title: Transformational...
Approximately 20 to 25 participants representing pharma, biotech, academia, and government will come together in July to help define the future of AI in pharmaceutical R&D...
Michael K. O'Brien, Ph.D., President and Founder of NGT BioPharma Consultants, has been named as an Industry Influence on The Medicine Maker 2019 Power List. The list, which...